MSD Partners, China's Panacea raise $200m SPAC to target biotech, life sciences sectors

MSD Partners, China's Panacea raise $200m SPAC to target biotech, life sciences sectors

Wall Street, New York City, NY. Source: Martin Ceralde/Unsplash

Eudora Wang

21 May, 2021

biotechChrystyna Bedrij StecykJames Huanglife sciencesMSD PartnersOrion Biotech Opportunities CorpPanacea Venture

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter

You may also like

Read more from Greater China

Nikkei Logo
DealStreetAsia Logo
About Us
Team
Advertise
Contact
Careers
Blog
Privacy Policy
Terms & Conditions
© Copyright DEALSTREETASIA 2014-2025 All rights reserved.